0001388658-20-000058.txt : 20200409 0001388658-20-000058.hdr.sgml : 20200409 20200409160809 ACCESSION NUMBER: 0001388658-20-000058 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 16 CONFORMED PERIOD OF REPORT: 20200409 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Regulation FD Disclosure ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20200409 DATE AS OF CHANGE: 20200409 FILER: COMPANY DATA: COMPANY CONFORMED NAME: iRhythm Technologies, Inc. CENTRAL INDEX KEY: 0001388658 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 208149544 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-37918 FILM NUMBER: 20784608 BUSINESS ADDRESS: STREET 1: 650 TOWNSEND STREET STREET 2: SUITE 500 CITY: San Francisco STATE: CA ZIP: 94103 BUSINESS PHONE: 415-632-5700 MAIL ADDRESS: STREET 1: 650 TOWNSEND STREET STREET 2: SUITE 500 CITY: San Francisco STATE: CA ZIP: 94103 FORMER COMPANY: FORMER CONFORMED NAME: IRhythm Technologies, Inc. DATE OF NAME CHANGE: 20110429 FORMER COMPANY: FORMER CONFORMED NAME: IRhythm Technologies Inc DATE OF NAME CHANGE: 20070201 8-K 1 irtc-20200409.htm 8-K irtc-20200409
0001388658false00013886582020-04-092020-04-09


 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549 
FORM 8-K 
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of report (Date of earliest event reported): April 9, 2020
iRhythm Technologies, Inc.
(Exact name of Registrant as specified in its charter) 
Delaware001-3791820-8149544
(State or other jurisdiction of
incorporation or organization)		(Commission
File Number)		(I.R.S. Employer
Identification Number)
699 8th Street, Suite 600
San Francisco, California 94103
(Address of principal executive office) (Zip Code)
(415) 632-5700
(Registrant’s telephone number, including area code)
N/A
(Former Name or Former Address, if Changed Since Last Report)
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading SymbolName of each exchange on which registered
Common Stock, Par Value $0.001 Per ShareIRTCThe NASDAQ Global Select Market
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
 



Item 2.01 Results of Operations and Financial Condition.

On April 9, 2020, we issued a press release (the “Press Release”) announcing preliminary revenue results for the fiscal quarter ended March 31, 2020. A copy of the Press Release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.

Item 7.01. Regulation FD Disclosure.

The Press Release also contains certain information related to the COVID-19 impact on our business and some of the efforts we have undertaken in response. In addition, we announced that we are withdrawing our previously announced annual guidance for 2020, which was issued on February 27, 2020 due to the rapidly evolving and continued uncertainties resulting from its impact. In addition, our Chief Executive Officer, our other named executive officers and other senior executives have agreed to base salary reductions and the directors on our board of directors have agreed to a reduction in their fees, until business and economic conditions improve.

Given the uncertain scope and duration of the COVID-19 pandemic, we are unable to estimate the impact of the COVID-19 outbreak on our operations and financial results. We plan to provide additional information during our first quarter earnings release and conference call based on the information available at that time.

The information in this Current Report on Form 8-K shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that Section, or incorporated by reference in any filing under the Securities Act of 1933, as amended (the “Securities Act”), or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.
Item 9.01.Financial Statements and Exhibits.
(d)Exhibits.
 


SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

IRHYTHM TECHNOLOGIES, INC.
Date: April 9, 2020By:/s/ Kevin M. King
Kevin M. King
Chief Executive Officer


 EX-99.1 2 irtcq12020ex991492020.htm EX-99.1 Document
Exhibit 99.1
irtclogoa041.jpg



iRhythm Technologies Announces Update on COVID-19 Impact and Response

Announces Preliminary Revenue Results for First Quarter of 2020; Withdraws 2020 Financial Guidance

SAN FRANCISCO, April 9, 2020 -- iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital health care solutions company focused on the advancement of cardiac care, today provided an update on the impact the company is experiencing due to the COVID-19 pandemic and the steps the company is taking in response. The company is also providing a preliminary range for revenue for its first quarter 2020 and is withdrawing full-year 2020 guidance.

“The COVID-19 pandemic has been an unprecedented challenge to the healthcare community and our society,” said Kevin King, CEO. “Through these challenging times, iRhythm is focused on supporting our employees, the patients we serve and our healthcare partners broadly. While we are all facing the challenges in different ways, we are encouraged by the incredible response and dedication of all those that are delivering care for patients and our communities at large. On behalf of everyone at iRhythm, we are sincerely grateful.”

Response to COVID-19
iRhythm is focused on the following priorities:

•Protecting and supporting the health and well-being of our employees, our communities and our customers by limiting the transmission of COVID-19.
Following recommendations from federal and local government and healthcare agencies, iRhythm transitioned employees to a remote work environment beginning in early March. For a small number of our employees who continue to support essential operations at our facilities, we have instituted social distancing and other measures to ensure the safety of our employees. As a testament to the resilience of the iRhythm team, we rapidly implemented business continuity protocols and have been able to transition to a remote operating environment while continuing to deliver our Zio service. We will continue to follow local and national guidelines to determine the appropriate time to resume in-office functions.

•Delivering uninterrupted patient care for both Zio XT and AT and supporting efforts to monitor COVID-19 patients.
While hospital systems and healthcare facilities shift their focus and resources to treating COVID-19 patients and combatting the spread of the coronavirus, we have adapted our service to meet the immediate needs of our physician customers and patients. Our digital service platform enables physician ordering, results reporting, data curation and patient support independent of location, across virtual or in-office care models. As an example, we have significantly increased the utilization of our Home Enrollment service. Home Enrollment allows patients to receive and wear the single-use Zio device without going to a healthcare facility. Physicians can prescribe Zio for their patients, either in-office or through a virtual care setting, and iRhythm ships Zio directly to the patient’s home. We guide patients through the patch application process and inform them of the instructions for wear. Home Enrollment also eliminates clinical staff exposure to cleaning or reusing traditional Holter and event monitors that may have been exposed to viruses or other pathogens.

In addition, health systems with acute needs to facilitate a reduction in healthcare provider contact and the additional need for monitoring capacity are looking to deploy Zio AT for inpatient monitoring. The FDA informed iRhythm that Zio AT usage for this application is consistent with the FDA COVID-19 Remote Monitoring guidance.

•Adjusting our operating plan as appropriate to ensure continued financial strength.
iRhythm continues to maintain a strong cash position and has taken initiatives to adjust our operating plan to ensure the company maintains appropriate liquidity during these uncertain times. The company has proactively taken initial steps to reduce spend, including eliminating or delaying project spend for non-essential programs, reducing spend on travel and consulting, and implementing a hiring freeze. In addition, our Chief Executive Officer, our other named executive officers and other senior executives have agreed to


base salary reductions and the directors on our board of directors have agreed to a reduction in their fees, until business and economic conditions improve.

Preliminary First Quarter Financial Results
Revenue for the three months ended March 31, 2020 is anticipated to be in the range of $61.0 million to $62.0 million, an increase of 26% to 28% compared to the same period in 2019. The company estimates an impact due to COVID-19 of approximately $2.0 million to $2.5 million in revenue in the first quarter of 2020. The company is currently conducting its closing process for the first quarter of 2020 including a review of the COVID-19 impact on the company’s reserves and is unable to provide a more precise estimate of its full financial results. Although the company cannot currently predict the extent or duration of the COVID-19 related impact to its financial results, the company does expect the impact of COVID-19 to be more significant in the near-term.

Cash and cash equivalents is anticipated to be approximately $122 million as of March 31, 2020.

Guidance for Full Year 2020
iRhythm is withdrawing its previously announced annual guidance for 2020, which was issued on February 27, 2020. Given the uncertain scope and duration of the pandemic, iRhythm is unable to estimate the impact of the COVID-19 outbreak on its operations and financial results. The Company plans to provide its complete financial results and additional information related to the impact of COVID-19 on its upcoming first quarter 2020 earnings call, which is expected to be in early May.

About iRhythm Technologies, Inc. iRhythm is a leading digital health care company redefining the way cardiac arrhythmias are clinically diagnosed. The company combines wearable biosensor devices worn for up to 14 days and cloud-based data analytics with powerful proprietary algorithms that distill data from millions of heartbeats into clinically actionable information. The company believes improvements in arrhythmia detection and characterization have the potential to change clinical management of patients.

Forward-Looking Statements
This news release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 and the Private Securities Litigation Reform Act of 1995. These statements include statements regarding financial guidance, market opportunity, ability to penetrate the market, operating plans and expectations for economic recovery. Such statements are based on current assumptions that involve risks and uncertainties that could cause actual outcomes and results to differ materially. These risks and uncertainties, many of which are beyond our control, include risks described in the section entitled “Risk Factors” and elsewhere in our filing made with the Securities and Exchange Commission on the Form 10-K on March 2, 2020. These forward-looking statements speak only as of the date hereof and should not be unduly relied upon. iRhythm disclaims any obligation to update these forward-looking statements.

Investor Relations Contact:Media Contact:
Lynn Pieper Lewis or Leigh Salvo Saige Smith
(415) 937-5404(262) 289-7065
investors@irhythmtech.comirhythm@highwirepr.com


EX-101.SCH 3 irtc-20200409.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0001001 - Document - Document and Entity Information Document link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 4 irtc-20200409_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 5 irtc-20200409_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 6 irtc-20200409_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Written Communications Written Communications Pre-commencement Tender Offer Pre-commencement Tender Offer Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Entity Address, City or Town Entity Address, City or Town Soliciting Material Soliciting Material Entity Address, Address Line One Entity Address, Address Line One Security Exchange Name Security Exchange Name Entity Address, Address Line Two Entity Address, Address Line Two City Area Code City Area Code Cover [Abstract] Cover [Abstract] Entity Central Index Key Entity Central Index Key Entity Tax Identification Number Entity Tax Identification Number Entity File Number Entity File Number Document Type Document Type Entity Emerging Growth Company Entity Emerging Growth Company Title of 12(b) Security Title of 12(b) Security Amendment Flag Amendment Flag Local Phone Number Local Phone Number Entity Address, State or Province Entity Address, State or Province Entity Address, Postal Zip Code Entity Address, Postal Zip Code Trading Symbol Trading Symbol Pre-commencement Issuer Tender Offer Pre-commencement Issuer Tender Offer Document Period End Date Document Period End Date Entity Registrant Name Entity Registrant Name EX-101.PRE 7 irtc-20200409_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT GRAPHIC 8 irtclogoa041.jpg begin 644 irtclogoa041.jpg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end ZIP 9 0001388658-20-000058-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001388658-20-000058-xbrl.zip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end EXCEL 11 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 12 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 13 irtc-20200409_htm.xml IDEA: XBRL DOCUMENT 0001388658 2020-04-09 2020-04-09 0001388658 false 8-K 2020-04-09 iRhythm Technologies, Inc. DE 001-37918 20-8149544 699 8th Street Suite 600 San Francisco CA 94103 415 632-5700 false false false false Common Stock, Par Value $0.001 Per Share IRTC NASDAQ false JSON 14 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "irtc-20200409.htm": { "axisCustom": 0, "axisStandard": 0, "contextCount": 1, "dts": { "calculationLink": { "local": [ "irtc-20200409_cal.xml" ] }, "definitionLink": { "local": [ "irtc-20200409_def.xml" ], "remote": [ "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-eedm-def-2019-01-31.xml", "http://xbrl.fasb.org/srt/2019/elts/srt-eedm1-def-2019-01-31.xml" ] }, "inline": { "local": [ "irtc-20200409.htm" ] }, "labelLink": { "local": [ "irtc-20200409_lab.xml" ], "remote": [ "https://xbrl.sec.gov/dei/2019/dei-doc-2019-01-31.xml" ] }, "presentationLink": { "local": [ "irtc-20200409_pre.xml" ] }, "referenceLink": { "remote": [ "https://xbrl.sec.gov/dei/2019/dei-ref-2019-01-31.xml" ] }, "schema": { "local": [ "irtc-20200409.xsd" ], "remote": [ "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://xbrl.fasb.org/us-gaap/2019/elts/us-roles-2019-01-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://xbrl.fasb.org/srt/2019/elts/srt-types-2019-01-31.xsd", "http://xbrl.fasb.org/srt/2019/elts/srt-roles-2019-01-31.xsd", "https://xbrl.sec.gov/country/2017/country-2017-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2019/elts/us-types-2019-01-31.xsd", "https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd" ] } }, "elementCount": 24, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2019-01-31": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 95, "memberCustom": 0, "memberStandard": 0, "nsprefix": "irtc", "nsuri": "http://www.irhythmtech.com/20200409", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "irtc-20200409.htm", "contextRef": "i933443fe5134471f9a4c0a2ca808479f_D20200409-20200409", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "0001001 - Document - Document and Entity Information Document", "role": "http://www.irhythmtech.com/role/DocumentandEntityInformationDocument", "shortName": "Document and Entity Information Document", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "irtc-20200409.htm", "contextRef": "i933443fe5134471f9a4c0a2ca808479f_D20200409-20200409", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.irhythmtech.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.irhythmtech.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]", "terseLabel": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.irhythmtech.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.irhythmtech.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.irhythmtech.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two", "terseLabel": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.irhythmtech.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.irhythmtech.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.irhythmtech.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province", "terseLabel": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.irhythmtech.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.irhythmtech.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.irhythmtech.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.irhythmtech.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "fileNumberItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code", "terseLabel": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.irhythmtech.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.irhythmtech.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.irhythmtech.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.irhythmtech.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "normalizedStringItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r2" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer", "terseLabel": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.irhythmtech.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r3" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer", "terseLabel": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.irhythmtech.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-US": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security", "terseLabel": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.irhythmtech.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r1" ], "lang": { "en-US": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.irhythmtech.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r4" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material", "terseLabel": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.irhythmtech.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.irhythmtech.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r6" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications", "terseLabel": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.irhythmtech.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "booleanItemType" } }, "unitCount": 0 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r5": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r6": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" } }, "version": "2.1" } XML 15 FilingSummary.xml IDEA: XBRL DOCUMENT 3.20.1 html 1 95 1 false 0 0 false 0 false false R1.htm 0001001 - Document - Document and Entity Information Document Sheet http://www.irhythmtech.com/role/DocumentandEntityInformationDocument Document and Entity Information Document Cover 1 false false All Reports Book All Reports irtc-20200409.htm irtc-20200409.xsd irtc-20200409_cal.xml irtc-20200409_def.xml irtc-20200409_lab.xml irtc-20200409_pre.xml irtcq12020ex991492020.htm http://xbrl.sec.gov/dei/2019-01-31 true true XML 16 R1.htm IDEA: XBRL DOCUMENT v3.20.1
Document and Entity Information Document
Apr. 09, 2020
Cover [Abstract]  
Document Type 8-K
Document Period End Date Apr. 09, 2020
Entity Registrant Name iRhythm Technologies, Inc.
Entity Incorporation, State or Country Code DE
Entity File Number 001-37918
Entity Tax Identification Number 20-8149544
Entity Address, Address Line One 699 8th Street
Entity Address, Address Line Two Suite 600
Entity Address, City or Town San Francisco
Entity Address, State or Province CA
Entity Address, Postal Zip Code 94103
City Area Code 415
Local Phone Number 632-5700
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Stock, Par Value $0.001 Per Share
Trading Symbol IRTC
Security Exchange Name NASDAQ
Entity Emerging Growth Company false
Entity Central Index Key 0001388658
Amendment Flag false
XML 17 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; }